Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,282,559,305
-
Number of holders
-
1,958
-
Total 13F shares, excl. options
-
1,090,277,471
-
Shares change
-
+8,414,259
-
Total reported value, excl. options
-
$87,892,843,380
-
Value change
-
+$696,533,584
-
Put/Call ratio
-
87%
-
Number of buys
-
1,128
-
Number of sells
-
-721
-
Price
-
$80.62
Significant Holders of Medtronic plc - Common Stock (MDT) as of Q1 2023
2,133 filings reported holding MDT - Medtronic plc - Common Stock as of Q1 2023.
Medtronic plc - Common Stock (MDT) has 1,958 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,090,277,471 shares
of 1,282,559,305 outstanding shares and own 85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (125,634,679 shares), BlackRock Inc. (117,686,656 shares), STATE STREET CORP (59,971,096 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (36,244,757 shares), Capital Research Global Investors (30,018,530 shares), WELLINGTON MANAGEMENT GROUP LLP (29,945,349 shares), BANK OF AMERICA CORP /DE/ (26,508,964 shares), GEODE CAPITAL MANAGEMENT, LLC (26,194,928 shares), JPMORGAN CHASE & CO (20,349,983 shares), and Bank of New York Mellon Corp (20,120,069 shares).
This table shows the top 1,958 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.